Roche wins Japan approval for personalized cancer drug Rozlytrek

Swiss drugmaker Roche's push into personalized cancer medicines hit a milestone on Tuesday with Japanese approval of a new drug, Rozlytrek, that targets patients who must be identified via genetic profiling.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news